InspireMD Inc (NSPR) with a beta value of 0.89 appears to be a promising investment opportunity.

InspireMD Inc (NASDAQ: NSPR) kicked off on Tuesday, down -9.16% from the previous trading day, before settling in for the closing price of $2.37. Over the past 52 weeks, NSPR has traded in a range of $0.96-$3.85.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 17.21%. While this was happening, its average annual earnings per share was recorded 7.32%. With a float of $15.02 million, this company’s outstanding shares have now reached $21.84 million.

Considering the fact that the conglomerate employs 66 people, you should pay attention to its efficiency factor.

InspireMD Inc (NSPR) Breakdown of a Key Holders of the stock

Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of InspireMD Inc is 35.97%, while institutional ownership is 35.92%. The most recent insider transaction that took place on Nov 30 ’23, was worth 126,540. In this transaction Director of this company bought 50,000 shares at a rate of $2.53, taking the stock ownership to the 438,902 shares. Before that another transaction happened on May 12 ’23, when Company’s Director bought 175,000 for $1.63, making the entire transaction worth $285,722. This insider now owns 248,534 shares in total.

InspireMD Inc (NSPR) Recent Fiscal highlights

In the latest quarterly report, which was put into the public domain on 12/30/2023, the organization reported -$0.16 earnings per share (EPS), higher than consensus estimate (set at -$0.19) by $0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.18 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 7.32% per share during the next fiscal year.

InspireMD Inc (NASDAQ: NSPR) Trading Performance Indicators

Take a look at InspireMD Inc’s (NSPR) current performance indicators. Last quarter, stock had a quick ratio of 6.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.12.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.17, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.96 in one year’s time.

Technical Analysis of InspireMD Inc (NSPR)

Compared to the last year’s volume of 38487.0, its volume of 0.22 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 52.68%. Additionally, its Average True Range was 0.17.

During the past 100 days, InspireMD Inc’s (NSPR) raw stochastic average was set at 17.33%, which indicates a significant increase from 0.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.15% in the past 14 days, which was lower than the 59.04% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $2.63, while its 200-day Moving Average is $2.89. Nevertheless, the first resistance level for the watch stands at $2.32 in the near term. At $2.50, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.58. If the price goes on to break the first support level at $2.06, it is likely to go to the next support level at $1.98. Now, if the price goes above the second support level, the third support stands at $1.80.

InspireMD Inc (NASDAQ: NSPR) Key Stats

The company with the Market Capitalisation of 50.44 million has total of 23,457K Shares Outstanding. Its annual sales at the moment are 6,210 K in contrast with the sum of -19,920 K annual income. Company’s last quarter sales were recorded 1,760 K and last quarter income was -5,410 K.